Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.

Published on Nov 10, 2020in Vaccine3.143
· DOI :10.1016/J.VACCINE.2020.09.084
Ran D. Goldman33
Estimated H-index: 33
(UBC: University of British Columbia),
Tyler Yan3
Estimated H-index: 3
(UBC: University of British Columbia)
+ 20 AuthorsGeorg Staubli11
Estimated H-index: 11
(Boston Children's Hospital)
Sources
Abstract
Abstract Background More than 100 COVID-19 vaccine candidates are in development since the SARS-CoV-2 genetic sequence was published in January 2020. The uptake of a COVID-19 vaccine among children will be instrumental in limiting the spread of the disease as herd immunity may require vaccine coverage of up to 80% of the population. Prior history of pandemic vaccine coverage was as low as 40% among children in the United States during the 2009 H1N1 influenza pandemic. Purpose To investigate predictors associated with global caregivers’ intent to vaccinate their children against COVID-19, when the vaccine becomes available. Method An international cross sectional survey of 1541 caregivers arriving with their children to 16 pediatric Emergency Departments (ED) across six countries from March 26 to May 31, 2020. Results 65% (n = 1005) of caregivers reported that they intend to vaccinate their child against COVID-19, once a vaccine is available. A univariate and subsequent multivariate analysis found that increased intended uptake was associated with children that were older, children with no chronic illness, when fathers completed the survey, children up-to-date on their vaccination schedule, recent history of vaccination against influenza, and caregivers concerned their child had COVID-19 at the time of survey completion in the ED. The most common reason reported by caregivers intending to vaccinate was to protect their child (62%), and the most common reason reported by caregivers refusing vaccination was the vaccine’s novelty (52%). Conclusions The majority of caregivers intend to vaccinate their children against COVID-19, though uptake will likely be associated with specific factors such as child and caregiver demographics and vaccination history. Public health strategies need to address barriers to uptake by providing evidence about an upcoming COVID-19 vaccine’s safety and efficacy, highlighting the risks and consequences of infection in children, and educating caregivers on the role of vaccination.
📖 Papers frequently viewed together
21 Citations
20193.14Vaccine
6 Authors (Daniel A. Norman, ..., Holly Seale)
13 Citations
5 Citations
References29
Newest
#1Jeremy K. Ward (Paris IV: Paris-Sorbonne University)H-Index: 13
Last. Olivier l'Haridon (CNRS: Centre national de la recherche scientifique)H-Index: 14
view all 3 authors...
Abstract : As Covid-19 spreads across the world, governments turn a hopeful eye towards research and development of a vaccine against this new disease. But it is one thing to make a vaccine available, and it is quite another to convince the public to take the shot, as the precedent of the 2009 H1N1 influenza illustrated. In this paper, we present the results of four online surveys conducted in April 2020 in representative samples of the French population 18 years of age and over (N=5,018). These...
51 CitationsSource
#1Eva W. Cheung (Columbia University)H-Index: 8
#2Philip Zachariah (Columbia University)H-Index: 13
Last. Joshua D. Milner (Columbia University)H-Index: 51
view all 7 authors...
This case series describes clinical characteristics, treatment, and outcomes of 17 previously healthy SARS-CoV-2-infected children and adolescents with an inflammatory phenotype overlapping with but distinct from Kawasaki disease and toxic shock syndrome admitted to a New York City hospital in late April and early May 2020.
263 CitationsSource
#1Linda Thunström (UW: University of Wyoming)H-Index: 14
#2Madison Ashworth (UW: University of Wyoming)H-Index: 5
Last. Stephen C. Newbold (UW: University of Wyoming)H-Index: 15
view all 4 authors...
The scientific community has come together in an unprecedented effort to find a COVID-19 vaccine. However, its success in the U.S. depends on the share of the population that gets vaccinated. We design a randomized controlled trial (RCT) survey in which a nationally representative sample of 3,133 participants state their intentions to vaccinate themselves and their children for COVID-19. We account for uncertainty about the severity and infectiousness of COVID-19 and potential inconsistencies in...
43 CitationsSource
#1Sarah Schaffer DeRoo (GW: George Washington University)H-Index: 1
#2Natalie Pudalov (GW: George Washington University)H-Index: 3
Last. Linda Y. Fu (GW: George Washington University)H-Index: 15
view all 3 authors...
156 CitationsSource
#1Marta Fadda (USI: University of Lugano)H-Index: 9
#2Emiliano Albanese (USI: University of Lugano)H-Index: 26
Last. L. Suzanne Suggs (USI: University of Lugano)H-Index: 16
view all 3 authors...
34 CitationsSource
#1Bijaya Kumar Padhi (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 11
#2Mohammed Al-Mohaithef (College of Health Sciences, Bahrain)H-Index: 3
Background Vaccine hesitancy is a potential threat to global public health. Since, there is an unprecedented global effort to develop a vaccine against the COVID-19 disease much less is known about its acceptance in the community. Understanding key determinants that influence the preferences and demands of a future vaccine by the community may help to develop strategies for improving the global vaccination program. This study aimed to assess the prevalence of the acceptancy of COVID-19 vaccine a...
12 CitationsSource
#1Kate Faasse (UNSW: University of New South Wales)H-Index: 18
#2Jill M. Newby (UNSW: University of New South Wales)H-Index: 24
Widespread and sustained engagement with health-protective behaviours (i.e., hygiene and distancing) is critical to successfully managing the COVID-19 pandemic. Evidence from previous emerging infectious disease outbreaks points to the role of perceived risk, worry, media coverage, and knowledge in shaping engagement with health-protective behaviours as well as vaccination intentions. The current study examined these factors in 2,174 Australian residents. An online survey was completed between 2...
12 CitationsSource
The World Health Organization has announced that 83 potential covid-19 candidate vaccines are being assessed (as at 23 April), including seven that have now been approved for human testing through clinical trials.1 The BMJ looks at what we know so far. Of the seven, three are being tested in Beijing. The vaccine company CanSino Biological, in collaboration with the Beijing Institute of Biotechnology, has the only vaccine in a phase II trial.2 The vaccine, which uses an adenovirus vector, is set ...
26 CitationsSource
814 CitationsSource
#1Nicole LurieH-Index: 66
#2Melanie SavilleH-Index: 18
Last. Jane HaltonH-Index: 1
view all 4 authors...
Developing Covid-19 Vaccines at Pandemic Speed An ideal vaccine platform would support development from viral sequencing to clinical trials in less than 16 weeks, demonstrate elicitation of consist...
649 CitationsSource
Cited By37
Newest
#1Courtney SuessH-Index: 14
Last. Seunghoon Lee (A&M: Texas A&M University)H-Index: 1
view all 0 authors...
Data from a survey of 1478 travelers and multistep group structural equation model analysis revealed that the Health Belief Model constructs of cues to action (trust in third-party information sources), perceived severity of and susceptibility to COVID-19, and beliefs about the protection benefits of a COVID-19 vaccine, subsequently elicited willingness to vaccinate and beliefs that others should vaccinate prior to travel and enhanced support for pre-travel vaccination mandates. Also, significan...
Source
#1Łukasz Dembiński (Medical University of Warsaw)H-Index: 2
Last. Katarzyna Albrecht (Medical University of Warsaw)H-Index: 1
view all 0 authors...
Stopping the COVID-19 pandemic and its socio-economic consequences is only possible with a multifaceted strategy, including mass vaccination. Studies have been conducted mainly in adults, and data on the pediatric population is relatively limited. However, it appears that vaccination in children and adolescents is highly effective and safe. Despite the apparent benefits of vaccinating this age group, there are some medical and ethical concerns. Based on the above considerations, the European Aca...
Source
#1Nusayba Ali (UCL: University College London)
#2Diane Ashiru-Oredope (UCL: University College London)H-Index: 17
Last. Sudaxshina Murdan (UCL: University College London)H-Index: 14
view all 0 authors...
Introduction: Covid-19 related vaccine hesitancy is a major problem worldwide and it risks delaying the global effort to control the pandemic. Covid-19 vaccine hesitancy is also higher in certain communities. Given that prescriber recommendation and community engagement are two effective ways of addressing vaccine hesitancy, training university students to become vaccination champions could be a way of addressing hesitancy, as the champions engage with their communities in their multiple identit...
Source
#1Alak Paul (University of Chittagong)H-Index: 8
#2Dwaipayan Sikdar (University of Chittagong)H-Index: 5
Last. Tapan Kumar Nath (University of Nottingham Malaysia Campus)H-Index: 13
view all 0 authors...
In order to eliminate COVID-19, many countries provided vaccinations. However, success depends on peoples' knowledge levels and rates of acceptance. But, previous research on this topic is currently lacking in Bangladesh. This cross-sectional study aimed at to investigate Bangladeshi peoples' knowledge, acceptance, and perception of challenges regarding COVID-19 vaccines. Quantitative data were collected using an online survey (n = 1975) and face-to-face interviews (n = 2200) with a pre-tested s...
Source
Source
#1Adrienne L Davis (U of T: University of Toronto)H-Index: 5
#2Alia Sunderji (U of T: University of Toronto)H-Index: 2
Last. Mark A Griffiths (Emory University)H-Index: 4
view all 18 authors...
OBJECTIVE: To determine if caregivers of children presenting to pediatric emergency departments (EDs) during the COVID-19 pandemic are delaying presenting to care for fear of contracting COVID-19. METHODS: This was a pre-planned secondary analysis of a cross-sectional survey study of caregivers accompanying their children aged 0-19 years to 16 pediatric EDs in 5 countries from May to June 2020. An anonymous online survey, completed by caregivers via RedCAP, included caregiver and child demograph...
Source
#1Junjie Aw (SingHealth)H-Index: 1
Last. Lian Leng Low (SingHealth)H-Index: 1
view all 0 authors...
Vaccine hesitancy forms a critical barrier to the uptake of COVID-19 vaccine in high-income countries or regions. This review aims to summarize rates of COVID-19 hesitancy and its determinants in high-income countries or regions. A scoping review was conducted in Medline®, Embase®, CINAHL®, and Scopus® and was reported in accordance with the PRISMA-SCr checklist. The search was current as of March 2021. Studies which evaluated COVID-19 vaccine hesitancy and its determinants in high-income countr...
1 CitationsSource
#1Paweł Sowa (UMB: Medical University of Białystok)H-Index: 4
#2Łukasz Kiszkiel (University of Białystok)H-Index: 3
Last. Karol Kamiński (UMB: Medical University of Białystok)H-Index: 20
view all 8 authors...
Since the declaration of the SARS-CoV-2 pandemic confirmed by World Health Organization, work on the development of vaccines has been stimulated. When vaccines are commonly available, a major problem is persistent vaccine hesitancy in many European countries. The main goal of our study was to understand the multidimensional factors inducing this phenomenon in Poland. Our study was carried out at the third wave’s peak of the pandemic, with record rates of daily cases and deaths associated with CO...
Source
#1Maria Giulia Salomoni (UNIBO: University of Bologna)
#2Zeno Di Valerio (UNIBO: University of Bologna)
Last. Davide Gori (UNIBO: University of Bologna)H-Index: 20
view all 7 authors...
Vaccination currently appears to be the only strategy to contain the spread of COVID-19. At the same time, vaccine hesitancy (VH) could limit its efficacy and has, therefore, attracted the attention of Public Health Systems. This systematic review aimed at assessing anti-COVID-19 vaccine acceptance rates worldwide and at identifying populations more prone to vaccine hesitancy, for which specific interventions should be planned. PubMed database was searched using a purposely formulated string. On...
Source
#1Madeleine Mant (U of T: University of Toronto)H-Index: 6
#2Asal Aslemand (U of T: University of Toronto)H-Index: 1
Last. Alyson Holland (McMaster University)H-Index: 2
view all 4 authors...
Purpose null To investigate university students' willingness to receive a COVID-19 vaccine when it becomes available to them. null Method null A multi-methods approach was used-online convenience sample surveys and semi-structured interviews-of young adults attending a large Canadian public university. Two survey samples were collected (June 20-July 28, 2020 and September 22-October 17, 2020). Semi-structured interviews were conducted following each survey, interviewing 20 students in each round...
Source